MACCS CVTeam Education
The Late Breakers: What you must know from ACC.26

Get up to speed on the top late breaking clinical trials that were presented in New Orleans at ACC.26.  Grab your cup of coffee, log on and quickly understand what your patients are going to be asking about and how it applies to your practice. This free session will enlighten and be enjoyable.   

Date: April 18

Time: 8:00-10:30 am EDT

Location: Zoom

Register Today

MDACC

PaACC

Elizabeth Luttner, PA-C

University of Pittsburgh Medical Center

Mavacamten in Symptomatic Adolescent Patients With Obstructive Hypertrophic Cardiomyopathy: Results From the Phase 3 Scout-HCM Trial

and

NOTIFY-HF: A Randomised Pilot Trial of Patient-Facing Heartlogic Alerts in Heart Failure Patients 

Speaker TBA

• Long-Term Survival Benefits and Disease Stabilization With Acoramidis In Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

• Safety and Preliminary Efficacy of AAVrh.10hFXN (LX2006) Gene Therapy in Friedreich Ataxia Cardiomyopathy

VCACC